[HTML][HTML] Apixaban in patients with atrial fibrillation
SJ Connolly, J Eikelboom, C Joyner… - … England Journal of …, 2011 - Mass Medical Soc
Background Vitamin K antagonists have been shown to prevent stroke in patients with atrial
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
[PDF][PDF] Apixaban in Patients with Atrial Fibrillation
SJ Connolly, J Eikelboom, C Joyner… - N Engl J …, 2011 - ryo1m.cocolog-nifty.com
Background Vitamin K antagonists have been shown to prevent stroke in patients with atrial
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
[引用][C] Apixaban in Patients with Atrial Fibrillation
SJ CONNOLLY, J EIKELBOOM… - The New England …, 2011 - pascal-francis.inist.fr
Apixaban in Patients with Atrial Fibrillation CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Francis Bibliographic Databases Simple search Advanced search Search by classification …
[引用][C] Apixaban in patients with atrial fibrillation.
S Connolly, J Eikelboom, C Joyner, H Diener… - NEW ENGLAND …, 2011 - arts.units.it
Apixaban in patients with atrial fibrillation
SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart… - 2011 - pubmed.ncbi.nlm.nih.gov
Background Vitamin K antagonists have been shown to prevent stroke in patients with atrial
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
Apixaban in patients with atrial fibrillation.
SJ Connolly, J Eikelboom, C Joyner… - The New England …, 2011 - europepmc.org
Background Vitamin K antagonists have been shown to prevent stroke in patients with atrial
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
Apixaban in patients with atrial fibrillation
SJ Connolly, J Eikelboom, C Joyner… - Briefings from the New …, 2011 - pure.au.dk
Vitamin K antagonists have been shown to prevent stroke in patients with atrial fibrillation.
However, many patients are not suitable candidates for or are unwilling to receive vitamin K …
However, many patients are not suitable candidates for or are unwilling to receive vitamin K …
[PDF][PDF] Apixaban in Patients with Atrial Fibrillation
SJ Connolly, J Eikelboom, C Joyner, HC Diener… - N Engl J …, 2011 - researchgate.net
Background Vitamin K antagonists have been shown to prevent stroke in patients with atrial
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
[PDF][PDF] Apixaban in Patients with Atrial Fibrillation
SJ Connolly, J Eikelboom, C Joyner, HC Diener… - N Engl J Med, 2011 - academia.edu
Background Vitamin K antagonists have been shown to prevent stroke in patients with atrial
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
fibrillation. However, many patients are not suitable candidates for or are unwilling to receive …
[引用][C] Apixaban in patients with atrial fibrillation
C SJ - N Engl J Med, 2011 - cir.nii.ac.jp
Apixaban in patients with atrial fibrillation | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …